| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2016-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba1a315eb173065fb5ad342762416ab8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e5dcf1ee03f49e9d1b1f92e0cf789ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60abd34cbfe18c86142d87d9e29352a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f65d0a7fe75daa83efe66597f8e989a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e66db5adb169768943c4a9be870a7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76d92a668970e1865ce1d020c54d2e49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9a06583045699477f9305abd7f8917 |
| publicationDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2990739-A1 |
| titleOfInvention |
Cgrp receptor antagonists |
| abstract |
The present invention provides a compound of Formula II: (II) or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2015-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |